Goldman Sachs Downgrades Auxilium Pharmaceuticals (AUXL) to Neutral
Tweet Send to a Friend
Goldman Sachs downgraded Auxilium Pharmaceuticals (NASDAQ: AUXL) from Buy to Neutral.Analyst Gary Nachman said, "We downgrade AUXL to Neutral from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
